Quantum Cyber N.V. General And Administrative Expense
Quantum Cyber N.V. (QUCY) reported General And Administrative Expense of $2.88 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:GeneralAndAdministrativeExpense · last filed 2025-09-26
- Quantum Cyber N.V. general and administrative expense for the quarter ending 2023-12-31 was $3.78M, a 79.32% increase year-over-year.
- Quantum Cyber N.V. general and administrative expense for the quarter ending 2023-09-30 was $2.75M, a 30.87% decline year-over-year.
- Quantum Cyber N.V. general and administrative expense for the quarter ending 2023-06-30 was $2.80M, a 43.30% decline year-over-year.
- Quantum Cyber N.V. general and administrative expense for the quarter ending 2023-03-31 was $1.59M, a 62.07% decline year-over-year.
| Period end | General And Administrative Expense 3 month | General And Administrative Expense 6 month | General And Administrative Expense 6 month as first filed | General And Administrative Expense 9 month | General And Administrative Expense 12 month | General And Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-06-30 | $2.88M 6-K · filed 2025-09-26 | |||||
| 2024-12-31 | $6.57M 20-F · filed 2025-03-31 | |||||
| 2024-06-30 | $4.52M 6-K · filed 2025-09-26 | |||||
| 2023-12-31 | $3.78M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | $6.53M derived: sum of 2 quarters · filed 2025-03-31 | $9.32M derived: sum of 3 quarters · filed 2025-03-31 | $11.41M 20-F · filed 2025-03-31 | ||
| 2023-09-30 | $2.75M 6-K · filed 2023-11-16 | $5.55M derived: sum of 2 quarters · filed 2023-11-16 | $7.63M 6-K · filed 2023-11-16 | $9.24M derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2023-06-30 | $2.80M 6-K · filed 2023-08-15 | $5.23M 6-K · filed 2024-10-18 | $4.88M 6-K · filed 2023-08-15 | $6.49M derived: sum of 3 quarters · filed 2025-03-31 | $10.47M derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-03-31 | $1.59M 6-K · filed 2023-05-16 | $3.70M derived: sum of 2 quarters · filed 2025-03-31 | $7.68M derived: sum of 3 quarters · filed 2025-03-31 | $12.61M derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2022-12-31 | $2.11M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | $6.08M derived: sum of 2 quarters · filed 2025-03-31 | $11.02M derived: sum of 3 quarters · filed 2025-03-31 | $15.21M 20-F · filed 2025-03-31 | $17.33M 20-F · filed 2023-04-07 | |
| 2022-09-30 | $3.98M 6-K · filed 2023-11-16 | $8.91M derived: sum of 2 quarters · filed 2023-11-16 | $13.10M 6-K · filed 2023-11-16 | |||
| 2022-06-30 | $4.93M 6-K · filed 2023-08-15 | $9.13M 6-K · filed 2023-08-15 | $9.27M 6-K · filed 2022-09-07 | |||
| 2022-03-31 | $4.19M 6-K · filed 2023-05-16 | |||||
| 2021-12-31 | $8.46M 20-F · filed 2024-04-09 | $8.48M 20-F · filed 2022-05-03 | ||||
| 2021-06-30 | $250.69K 6-K · filed 2022-09-07 | |||||
| 2020-12-31 | $374.57K 20-F · filed 2023-04-07 | |||||
| 2019-12-31 | $428.86K 20-F · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |